Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.
about
(-)-Epicatechin rescues the As2 O3 -induced HERG K(+) channel deficiency possibly through upregulating transcription factor SP1 expression.Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy.Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress.
P2860
Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rationale and efficacy of prot ...... acute promyelocytic leukemia.
@en
Rationale and efficacy of prot ...... acute promyelocytic leukemia.
@nl
type
label
Rationale and efficacy of prot ...... acute promyelocytic leukemia.
@en
Rationale and efficacy of prot ...... acute promyelocytic leukemia.
@nl
prefLabel
Rationale and efficacy of prot ...... acute promyelocytic leukemia.
@en
Rationale and efficacy of prot ...... acute promyelocytic leukemia.
@nl
P2093
P2860
P50
P356
P1433
P1476
Rationale and efficacy of prot ...... f acute promyelocytic leukemia
@en
P2093
A Srivastava
H K Palani
N Balasundaram
P Balasubramanian
P2860
P2888
P304
P356
10.1038/LEU.2016.227
P577
2016-08-18T00:00:00Z